D-ISN/Collaborative Research: Financial and Network Disruptions in Counterfeit and Illegal Medicines Trade08/01/2022 - 07/31/2026 (PI)
National Science FoundationCMMI-2146458
Governing the global antimicrobial commons in a sustainable, acceptable, fair and effective (SAFE) manner10/01/2022 - 09/30/2025 (Subcontract PI)
York University, Toronto SoSci & Hum Res Coun
Evaluation of Feasibility for Grand Challenges Pakistan Partnership II04/23/2020 - 09/30/2025 (PI)
Bill and Melinda Gates Foundation
Exploratory country case studies12/17/2024 - 07/01/2025 (PI)
World Health Organization
Health of Refugees and Forcibly Displaced Communities06/16/2023 - 07/01/2025 (PI)
Wellcome Trust
US and EU Border Externalization Regimes: Ethics, Identities, and Impacts01/01/2023 - 06/30/2025 (Multi-PI)
PI:
Muhammad Zaman, PhDThe Andrew W. Mellon Foundation
Fellowship in Quality of Medical Products at Boston University05/08/2018 - 11/30/2024 (PI)
United States Pharmacopeial Convention
Aptamer Development for the PharmaChk Platform07/20/2020 - 06/20/2024 (PI)
Merck KGaA (Germany)
2021 DCLC - Dr. Muhammad Zaman04/01/2021 - 03/31/2023 (PI)
Howard Hughes Medical Institute
Measuring AMR footprint in Pakistan01/01/2021 - 09/30/2022 (PI)
DAI
Showing 10 of 40 results.
Show All Results
D-ISN: TRACK 2: Collaborative Research: Financial Network Disruptions in Illicit and Counterfeit Medicines (FIND-M)09/01/2020 - 08/31/2022 (PI)
National Science FoundationIIS-2039785
Documenting UNICEF's work in Health Sector in Humanitarian Settings using modelling, YR206/22/2021 - 06/21/2022 (PI)
United Nations Children's Fund
Evaluation of Feasibility for Grand Challenges Pakistan Partnership03/01/2019 - 12/31/2021 (PI)
Bill and Melinda Gates Foundation
New Awards for Science Education to HHMI Professors09/01/2014 - 08/31/2021 (PI)
Howard Hughes Medical Institute
Documenting UNICEF's work in Health Sector in Humanitarian Settings using modelling10/02/2019 - 11/13/2020 (PI)
United Nations Children's Fund
A Blood Filtration System for Malaria Diagnostics10/01/2019 - 09/30/2020 (Subcontract PI)
University of Oxford Wellcome Trust
Analyzing performance of a quantitative, affordable and user-friendly drug quality analysis system09/20/2018 - 09/19/2020 (PI)
Merck KGaA (Germany)
Epithelial layer jamming in cancer cell migration09/23/2015 - 08/31/2020 (Subcontract PI)
Harvard School of Public Health NIH NCI5U01CA202123-05
Tumor invasion as non-equilibrium phase separation09/01/2018 - 08/31/2019 (Subcontract PI)
Harvard School of Public Health NIH NCI5U01CA202123-04
Physics of Collective Cellular Migration in Lung Health and Disease08/01/2014 - 06/30/2019 (Subcontract PI)
Harvard School of Public Health NIH NHLBI5P01HL120839-05
PharmaChk: Substandard and Counterfeit Medicines Rapid Detection and Screening Platform04/13/2015 - 04/12/2019 (PI)
U.S. Agency for International DevelopmentAID-OAA-A-15-00029
Lancet Global Health Commission on High Quality Health Systems in the SDG Era (HQSS Commission)10/01/2017 - 03/31/2019 (Subcontract PI)
Harvard School of Public Health Bill & Melinda Gates
Modeling Bi-Directional Signaling and Cytoskeletal Dynamics in 3D Cell Migration04/01/2016 - 03/31/2019 (Multi-PI)
PI:
Muhammad Zaman, PhDNIH/National Cancer Institute5U01CA177799-05
Co-artem testing on PharmaChk01/04/2017 - 12/31/2018 (PI)
Novartis Pharma AG
Implementation of PharmaCheck to assure the quality of IMCI drugs in Indonesia09/01/2014 - 12/31/2018 (Subcontract PI)
Center for Health Research, Universitas Indonesia USAID
Aptamer development partnership10/03/2016 - 09/25/2018 (PI)
GlaxoSmithKline Research & Development Limited
Center for Innovation in Point of Care Technologies for the Future of Cancer Care07/01/2012 - 06/30/2017 (Co-Investigator of Sub-Project / SP)
PI:
Catherine M. Klapperich, PhDNIH/National Institute of Biomedical Imaging & Bioengineering5U54EB015403-04
Characterizing Cell Morphology, Adhesion, and Migration in 2.5 and 3D Cell-Derived Extracellular Matrices09/01/2012 - 02/28/2017 (PI)
National Science FoundationDMR-1206635
Developing Superior Screening Technology for Medicine Quality Control in Low Resource Countries03/01/2015 - 12/31/2016 (Subcontract PI)
United States Pharmacopeial Convention USAID
The Development of a Reliable and Robust Oxygen Concentrator Platform for Use in Low-Resource Settings06/01/2014 - 06/30/2016 (Subcontract PI)
PATH Bill & Melinda Gates
Modeling Bi-Directional Signaling and Cytoskeletal Dynamics in 3D Cell Migration04/16/2013 - 03/31/2016 (Multi-PI)
PI:
Muhammad Zaman, PhDNIH/National Cancer Institute5U01CA177799-03
MECHANICS OF MONOLAYER MIGRATION04/06/2011 - 03/31/2016 (Subcontract PI)
President and Fellows of Harvard College NIH NHLBI5R01HL107561-05
PharmaCheck11/01/2012 - 12/31/2014 (PI)
National Collegiate Inventors and Innovators Alliance
PharmaCheck: Counterfeit and Substandard Drug Detector Device for the Developing World11/07/2012 - 11/06/2014 (PI)
U.S. Agency for International DevelopmentAID-OAA-F-13-00004
DEVELOPING SUPERIOR SCREENING TECHNOLOGY FOR MEDICINES QUALITY CONTROL IN LOW RESOURCE COUNTRIES05/01/2011 - 09/30/2014 (Subcontract PI)
United States Pharmacopeial Convention USAID
U.S. Pharmacopia Fellowship for Darash Desai09/01/2012 - 11/30/2013 (PI)
United States Pharmacopeial Convention
Center for Systematic Modeling of Cancer Development Pilot Project: Multi-scale modeling of molecular and cellular events in 3D tumor cell migration07/01/2012 - 08/31/2013 (Subcontract PI)
The Methodist Hospital, d/b/a Houston Methodist Hospital NIH NCI5U54CA149196-03
QUANTITATIVE ANALYSIS OF TUMOR CELL MIGRATION IN THREE DIMENSIONAL MATRICES09/01/2009 - 07/31/2013 (Multi-PI)
PI:
Muhammad Zaman, PhDNIH/National Cancer Institute5R01CA132633-05
Seed Grant-Arab American Frontiers04/01/2012 - 09/30/2012 (Subcontract PI)
National Academy of Sciences USAID
MAKING AN 'IMPACT' (INTEGRATED MEASURING PLATFORM FOR IDENTIFYING & TESTING ANTI-CANCER THERAPEUTICS) ON PEDIATRIC CANCERS06/01/2010 - 09/30/2012 (Subcontract PI)
University of Manchester/MIMIT Eng & Phy Sci Res UK